Unicycive shareholders elect four directors and approve reverse stock split at 2025 annual meeting

Unicycive Therapeutics, Inc.

All four director nominees elected: Dr. Aggarwal, Dr. Gupta, Dr. Laumas, Dr. Kenkare-Mitra.
Ratification of Grassi & Co. as independent auditor approved (87.8M for, 531.6K against).
Reverse stock split proposal approved (78.1M for, 9.6M against, 771.4K abstain).
69.7% of total voting power was represented at the meeting (88.4M of 126.9M votes).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.